Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.14 USD | +2.61% | -6.82% | -15.06% |
Apr. 17 | Sector Update: Health Care Stocks Mixed Wednesday Afternoon | MT |
Apr. 17 | NeuroBo Begins Dosing in Phase 1 Study of Obesity Treatment; Shares Rise | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 15.4M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -29M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.9
x | P/E ratio 2025 * |
-1.41
x | Employees | 8 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.33% |
1 day | +2.61% | ||
1 week | -6.82% | ||
Current month | -23.23% | ||
1 month | -26.98% | ||
3 months | +2.28% | ||
6 months | -10.59% | ||
Current year | -15.06% |
Managers | Title | Age | Since |
---|---|---|---|
Hyung-Heon Kim
CEO | Chief Executive Officer | 47 | 21-07-08 |
Director of Finance/CFO | 66 | 23-10-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
D. Strickland
BRD | Director/Board Member | 77 | 22-01-26 |
Andrew Koven
CHM | Chairman | 66 | 21-07-08 |
Mark Glickman
BRD | Director/Board Member | 58 | 23-05-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 3.14 | +2.61% | 17,307 |
24-04-25 | 3.06 | -1.29% | 1,823 |
24-04-24 | 3.1 | +2.65% | 39,360 |
24-04-23 | 3.02 | -3.21% | 42,194 |
24-04-22 | 3.12 | -7.42% | 23,389 |
Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.06% | 15.4M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- NRBO Stock